Related by context. Frequent words. (Click for all words.) 67 NASDAQ CRXL 66 treat male hypogonadism 66 LifeCell Corporation 65 imaging neurodegenerative disorders 65 NYSE Amex INO 65 SG pulmonary 65 Initiates Phase II 64 protein ADNP 64 malignant infectious 64 activity dependent neuroprotective 64 Completes Patient Enrollment 64 PRNewswire FirstCall Halozyme Therapeutics 64 cartilage regeneration 63 autologous cell 63 Thiarabine 63 oncolytic virus therapies 63 metastatic colorectal 63 optical biosensors 63 therapeutic monoclonal antibodies 63 topical non steroidal 63 BY JOHN ECKBERG 63 Onalta 63 Antigen Express comprise immunotherapeutics 63 regarding Aethlon Medical 63 BY RYAN ERNST 63 factor VIIa 63 Mesoblast Limited ASX MSB 63 PRNewswire FirstCall CryoLife 62 WITHOUT ANY WARRANTIES 62 autologous adult 62 poly ADP ribose polymerase 62 genomic proteomic 62 fibrosis IPF 62 MediVas 62 cet article est réservé 62 epothilones 62 Biomagnetics Diagnostics Corporation 62 HEREBY DISCLAIMS ANY SUCH 62 Crucell NV Euronext 62 Potassium Chloride Sodium Ascorbate 62 ATS CryoMaze TM 62 Marcus Gronholm BP 62 trading house.net AG 62 Sie lesen Finanznachrichten und 62 lung pancreatic 62 based pretargeting methods 62 THE COMPANY WHO TAKES 62 ® bortezomib 62 PURCHASE LETTER OF TRANSMITTAL 62 stable nucleic acid 61 regenerative tissue 61 MVA BN R 61 By MICHAEL FORTUNA 61 formalin fixed 61 orthobiologic 61 liposomal formulation 61 cesium formate drilling 61 Litx 61 Bone Graft 61 THE SOLICITATION OF 61 Clearant Inc. 61 OR ASSIGNS MAY BE 61 MATERIALLY FROM ANY FUTURE 61 By NATALIA E. 61 mediate RNAi 61 polyclonal antibodies 61 Receives Orphan Drug Designation 61 THAT ARE SUBJECT TO 61 WHICH ARE NOT PURELY 61 Ibis T# 61 INACCURACIES IN THE DOW 61 sorafenib tablets 61 Meets Primary Endpoint 61 Nasdaq ATEC 61 huC# DM4 61 topical anti infective 61 R sorafenib tablets 61 Amgen discovers develops 61 Factor VIIa 61 ANY RESPONSIBILITY FOR ANY 61 SEE CONTINUED DOWNWARD MOMENTUM 61 By BOB AUDETTE 61 Nasdaq ASTM 61 commercializes proprietary 61 Nasdaq CRXL 61 Mitteilung ist der Emittent 61 peptide fragments 61 THEY CONTAIN IMPORTANT INFORMATION 61 target Galectin receptors 61 markets therapeutic ultrasonic 61 MassARRAY R 61 theranostic 60 radiotherapeutic 60 oncolytic viruses 60 BAG# BAG# 60 IMPORTANT FACTORS THAT COULD 60 Colorado Coagulation Endocrine Sciences 60 IS PROVIDED AS IS 60 VEGFR2 inhibitor 60 G Protein Coupled 60 reconstructive orthopedic